David J. Brailer - Feb 28, 2025 Form 4 Insider Report for Cigna Group (CI)

Role
EVP & Chief Health Officer
Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
Feb 28, 2025
Transactions value $
-$1,042,065
Form type
4
Date filed
3/4/2025, 07:52 PM
Previous filing
Sep 4, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +6.54K +72.33% $0.00 15.6K Feb 28, 2025 Direct F1
transaction CI Common Stock, $.01 Par Value Award $0 +5.64K +36.2% $0.00 21.2K Feb 28, 2025 Direct F2
transaction CI Common Stock, $.01 Par Value Tax liability -$237K -775 -3.65% $305.86 20.4K Feb 28, 2025 Direct F3
transaction CI Common Stock, $.01 Par Value Tax liability -$805K -2.63K -12.87% $305.86 17.8K Feb 28, 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +23.2K $0.00 23.2K Feb 28, 2025 Common Stock, $.01 Par Value 23.2K $305.86 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in full on March 1, 2026.
F2 The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F3 Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F4 Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F5 This option vests in full on March 1, 2026.

Remarks:

Exhibit List: EX-24 Power of Attorney poabrailer.txt